skip to main content

Multicenter, noninterventional, post-marketing surveillance study to evaluate dosing of recombinant human follicle-stimulating hormone using the redesigned follitropin alfa pen in women undergoing ovulation induction

Nawroth F ; Tandler-Schneider A ; Bilger W

Drug, Healthcare and Patient Safety, 01 April 2015, Vol.2015(default), pp.63-68 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Buscando em bases de dados remotas. Favor aguardar.